GlaxoSmithKline Pharmaceuticals Ltd has announced a 16 per cent drop in net profits for the quarter ended December 2013 at Rs 116.80 crore ( Rs 138.5 crore).
In the same period, total income decreased from Rs 704.34 crore for the quarter ended December 31, 2012 to Rs 685.04 crore for the quarter ended December 31, 2013. For the full year ended December 31, 2013, the company posted a net profit of Rs 501.88 crore on an income of Rs 2,747.1 crore as against a profit of Rs 577.2 crore on an income of Rs 2823.78 crore in the previous year.
The board has recommended a dividend of Rs 50 per share.
Comments
Comments have to be in English, and in full sentences. They cannot be abusive or personal. Please abide by our community guidelines for posting your comments.
We have migrated to a new commenting platform. If you are already a registered user of TheHindu Businessline and logged in, you may continue to engage with our articles. If you do not have an account please register and login to post comments. Users can access their older comments by logging into their accounts on Vuukle.